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230 ± 117 mg/dl (p < 0.001 ) at 2 hours after meal, 258 ± 159 mg/dl (p < 0.001) at 4 hours 
after meal, and 178 ± 114 mg/dl (p = 0.011) at 6 hours after meal. FMD fell from 9.3 + 3.7 
% before meal to 5.2 + 2.3 % (p < 0.001) at 2 hours after meal, 5.9 ± 3.5 % (p = 0.001) at 
4 hours after meal, and 6.6 ± 2.8 % (p = 0.007) at 6 hours after meal. Serum GP signifi- 
cantly decreased from 136 + 62 ng,'ml to 128 + 59 ng/ml (p = 0.022) at 2 hours after meal, 
and returned to 131 ± 59 ng/ml (p = 0.115), and 134 ± 56 ng/ml (p = 0.657) at 4 and 6 
hours after meal respectively. Urinary excretion of 8-PGF2~x was 1286 + 1401 pg/mg cre- 
aUnine before meal, 1497 ± 1278 pg/mg creatinine (p = 0.733) at 2 hours after meal, but 
significantly increased to 2197 ± 1343 pg/mg creatinine (p = 0.014) at 4 hours after meal, 
and returned to 1114 ± 986 pg/mg creatinine (p = 0.762) at 6 hours after meal. 
Concluilon: Depletion of serum antioxidative enzymes occurred early after high-fat 
meal and followed by increased excretion of oxidative modification products in urine. 
Increased oxidative stress occurred after a high-fat meal might be responsible for endot- 
helial dysfunction caused by postprandial hypertdglyceridemia. 
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BACKGROUND. Many investigators report that dietary factors exert their influence on 
cardiovascular disease (CVD) largely through their effects on blood Lipide and lipopro- 
teens, as well as on the other established modifiable risk factors. In this work we aimed to 
evaluate the impact of the Mediterranean-type of diet on several clinical and biochemical 
markers, associated to CVD risk. 
METHODS. The ATTICA study is a prospective population -based cohort designed to 
enroll 3073 men and women from the greater area of Athens. A random algorithm was 
developed and stratified, by sex- age; sampling was performed, during 2001. In this work 
we analyzed data from 520 men (18-86 years old) and 580 women (18-80 years old). 
The consumption of red meat, chicken, fishes, vegetables, legumes, pasta, salads, cere- 
als, diary products, sweets and fruits was investigated as an average per week, during 
the past year, using a special nutritional questionnaire, developed by the National School 
of Public Health. We defined subjects who adopt this type of diet using as cut-off points 
the median values of the monthly food consumption score. 
RESULTS. 684 (57%) of the subjects were more close to the Mediterranean diet. The 
adoption of Mediterranean diet reduces significantly total cholesterol (203±29 vs. 212 
±33 mg/dl, P<0.05), triglycerides (112±17 vs. 127 ±19 mg/d[, P<0.01), blood glucose 
concentration (90±8 vs. 94 ±12 mg/dl, P<0.01), fibrinogen (323±36 vs. 346± 32 mg/dl, 
P<0.05), homecysteine (12±3 vs. 14± 5 mg/dl, P<0.05) and diastolic/systolic blood pres- 
sures (75/123 ± 9/12 vs. 77/127 ± 8/12 mmHg, P<0.01). On the other hand, diet 
increases HDL-cholesterol (51±6 vs. 48± 3 mg/dl, P<0.01) and apoA1 (167±23 vs. 157 
±22 mg/dl, P<0.01). No associations were found between the adoption of Mediterranean 
diet and Lp(a), uric acid, social status (described by educational and financial level), age 
and sex (P>0.700). 
CONCLUSION. Despite the "ecological" paradox regarding low CVD mortality in Mediter- 
ranean populations, where Keys and his colleagues reported at the eady 1970s, the pro- 
tective effect of this traditional diet on atherosclerosis seems to be explained, mainly, due 
to the modification of several biochemical and clinical markers. 
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Background: The highly atherogenic small/dense LDL particles are more prevalent in 
those with triglyceride (TG) levels above 150 rag/hi. 
Methods and Results: The aim of the present study was to evaluate the effects of 4 
weeks of NCEP step II diet on tipeproteins particle size and subclasses distribution relat- 
ing them to basal TG levels. The study included 36 coronary heart disease patients with 
LDL-cholesterol (LDL-C) levels above 130 mg/dl. Nuclear magnetic resonance spectros- 
copy of plasma was used to assess the concentrations of total cholesterel (TC), TG and 
fipoprotein-lipids, lipoproteins size and subclasses distribution. Statistical methods: 2-fac- 
tor repeated measure ANOVA. The patients were separated into 2 groups depending on 
baseline TG levels: below or above 150 mg/dL Low and high TG groups presented basal 
differences in TG and HDL-C levels. TC and LDL-C were no different. The changes in 
lipid levels in low and high TG groups were respectively (all comparisons are low vs. high 
TG groups changes in the 4 weeks): TC changed from 238 ± 43 to 239 ± 41 and 239 ± 
32 to 213 ± 32 mg/dl (p = 0.001 ), TG from 111 ± 23 to 125 ± 32 and 229 ± 74 to 174 ± 82 
mg,'dt (p = 0.0001), LDL-C from 174 ± 42 to 175 ± 38 and 168 ± 30 to 145 ± 30 mg/dl (p 
= 0.002) and HDL-C from 40 ± 6 to 40 ± 7 and 33 ± 9 to 35 ± 9 mg/dl (ns). Changes in 
lipoprotein size were respectively: VLDL size from 41.4 ± 3.7 to 45.8 ± 5.2 and 55.2 ± 
12.3 to 49.0 ± t2.0 nm (p = 0.001 ), LDL size from 21.0 ± 0.5 to 20.0 ± 0.7 and 20.0 ± 0.7 
to 20.5 ± 0.8 nm (p = 0.04) and HDL size from 83 ± 0.2 to 8.7 ± 0.2 and 8.4 ± 0.3 to 8.6 
± 0.3 nm (p = 0.0003). Changes in lipoprotein subclasses were respectively: larger VLDL 
particles (V6 and V5) from 5 ± 7 to 11 ± 13 and 77 ± 84 to 43 ± 72 mg/dl (p = 0.01 ), small 
and dense LDL particles (L1) from 26 ± 38 to 28 ± 36 and 91 ± 52 to 52 ± 60 mg/dl (p = 
0.01), larger HDL particles (corresponding to HDL2b and 2a) from 18 ± 5 to 18 ± 4 and 9 
± 7 to 12 ± 7 mg/dl (p = 0.001). 
Conclusion: A period of four weeks of NCEP step II diet decreased VLDL and increase 
LDL and HDL particle size only in patients with TG above 150 rag/de. This changes occur 
respectively by decrease of large VLDL and small and dense LDL subfractions and 
increase of large HDL particles. Small/dense LDL were decreased only in high TG group. 
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Background: We sought to determine whether consumption of not-from-concentrate 
orange juice (O J) which is rich in potassium, vitamin-C and anti-oxidants twice a day 
would improve endothelial function and reduce blood pressure in patients with coronary 
disease. Methods: We recruited 24 non-diabetic patients with angiographic CAD (>50% 
stenosis), well controlled hypertension and lipids to test the effects of formulations of 
orange juice on endothelial function as assessed by blood pressure, brachial artery flow 
mediated dilation, and lipid levels. Patients were followed at two week intervals without 
medication change for a total of 14 weeks; 2-week vitamin-C fortified juice drink (JD), 
orange juice (O J) alone, OJ fortified with vitamin-C and OJ fortified with vitamins C and 
E, and a 2-week washout (we) period without est products. Flow mediated dilation and 
the average of four resting BP readings each at least 5 minutes apart were recorded 
every two weeks. Results: After adjustment for age, gender, and baseline BP, OJ 
resulted in reductions in systolic (median -6.9%, p<0.001) and diastolic BP (median - 
3.5%, p--0.07). In addition, OJ use tended to be associated with improvements in %FMD; 
o o Baseline 8.3% ± 4.7, OJ 9.2 '/o + 2.5, we 7.6 '/o ± 4.8. [All OJ vs. Baseline (ns), all OJ vs. 
we  (p=0.058)]. Conclusion: Orange juice appears to positively influence vascular regu- 
lation, and may have implications for public health strategies towards blood pressure 
control. 
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BACKGROUND:Postprandial lipemia (PPL) after a fatty meal is elevated in patients (pts) 
with established coronary artery disease (CAD), which is known to worsen coronary and 
carotid disease progression• How eady this response becomes abnormal is not known• 
These pts are usually treated with beta-blookers (BB) which can worsen the fasting lipid 
profile, but whose effects on PPL have not been previously investigated. The aims of this 
study are to evaluate the PPL in a group of pts soon after a first coronary event and 
assess the effects of BB on PPL 
METHODS:PPL after a standard fatty meal and the effect of BB therapy on PPL were 
studied in 50 pts with no previous history of CAD, one month after a first acute coronary 
event. Fifty healthy volunteers (sex- and age-matched) served as controls. Since admis- 
sion half of the pts were randomized to oral atenolol. Clinical data, fasting laboratohes, 
and 8-hour PPL curves after a standard faffy meal were obtained for all pts and controls. 
RESULTS:Compared with controls, the pts had higher fasting triglyceride and very-low- 
density liboprotein (VLDL) cholesterol levels (P<0.01); higher and more prolonged PPL 
curves at 2, 4, 6, and 8 hours (P<0.01); with a 76% higher mean exposure to postpran- 
dial triglycerides. Atenolol did not affect the PPL profile. 
Po>"t-Prahdial Lipemia with and with out| 
Beb-B oQkers =om~ared ~uith ~ottro s I 
3OOT 
"It 
100x~lb ,=. l r |  
^ I ~ I I P P ~  IN0 BB} 
j -  4 6 ~ Cord~ls 
Time (Hr) " 
CONCLUSIONS:Thirty clays after a first acute coronary event pts with no previous his- 
tory of CAD already exhibit an abnormal PPL in response to a fatty meal Atenolol has no 
effect on PPL or fasting triglyoeride in this population. 
